Truist Securities Maintains Buy on Exelixis, Raises Price Target to $56

Benzinga · 07/15 15:35
Truist Securities analyst Asthika Goonewardene maintains Exelixis (NASDAQ:EXEL) with a Buy and raises the price target from $55 to $56.